CompletedNot Applicable

Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch

Canada11 participantsStarted 2013-11

Plain-language summary

The aim of the present study is to determine if there is a change in quality and quantity of sleep perceived by adults and children with GSD and their parents while starting a modified UCCS (Glycosade) to prevent nocturnal hypoglycemia. The investigators also aim to evaluate if there is a change in quality of life perceived by adults and children and their parents with Glycosade.

Who can participate

Age range2 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients of ≥ 2 years old with a diagnostic of GSD 0, I, III, VI, IX or XI based on a liver biopsy, mutation in the appropriate gene or clinical evidence of GSD with a positive familial history * Medical history of fasting hypoglycemia * Currently taking standard UCCS * With a stable condition * Followed in GSD clinics at the Montreal Children's Hospital and the Hôpital St-Luc * With informed consent obtained Exclusion Criteria: * Continuous overnight feeds

What they're measuring

The aim of the present study is to determine if there is a change in quality and quantity of sleep perceived by GSD adults and children and their parents while starting a modified UCCS (Glycosade) to prevent nocturnal hypoglycaemia.

Timeframe: 2 weeks

Trial details

NCT IDNCT02054832

SponsorJohn Mitchell

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-07

View on ClinicalTrials.gov More Glycogen Storage Disease Type IA trials